Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy
Open accessThe DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
Objective: To conduct a clinicopathologic study to characterize clinical and neuropathologic features associated with cognitive impairment in participants with no neuritic amyloid plaques (primary age-related tauopathy [PART] definite) and sparse neuritic plaques (amyloid sparse). Methods: Using the National Alzheimer9s Coordinating Center database, we identified 377 individuals who were PART definite (n = 170) or amyloid sparse (n = 207), clinically examined within 1 year of death, and autopsied at 1 of 26 National Institute on Aging–funded Alzheimer9s Disease Centers. Factors associated with the odds of being symptomatic (global Clinical Dementia Rating [CDR] score >0) were identified with multivariable logistic regression. Results: PART-definite participants less often had a high Braak neurofibrillary tangle stage V or VI (4%) compared to amyloid sparse participants (28%, p < 0.001). Of the PART-definite participants, 98 were symptomatic and 72 asymptomatic according to their global CDR scores. PART-definite participants were less often symptomatic (58%) compared with amyloid sparse participants (80%, p < 0.001). Within the PART-definite group, independent predictors of symptomatic status included depression (adjusted odds ratio [aOR] 4.20, 95% confidence interval [CI] 2.15–8.19), Braak stage (aOR 1.42, 95% CI 1.04–1.95), and history of stroke (aOR 8.09, 95% CI 2.63–24.82). Within the amyloid sparse group, independent predictors of symptomatic status included education (aOR 0.80, 95% CI 0.65–0.99), Braak stage (aOR 1.91, 95% CI 1.07–3.43), and amyloid angiopathy (aOR 2.75, 95% CI 1.14–6.64). Conclusions: These findings support the hypothesis that participants with PART have an amyloid-independent dementing Alzheimer disease–like temporal lobe tauopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,894 · cited 1×
“PART definite overlaps with the “not AD neuropathologic change” and AS with the “low AD neuropathologic change” categories set forth by the National Institute on Aging (NIA)–Alzheimer’s Association guidelines for AD neuropathologic assessment.(19) PART-definite participants were less often symptomatic (58%) than AS pa…”
MethodPrimary age-related tauopathy (PART): a common pathology associated with human aging
Crary, J. F., Trojanowski, J. Q., Schneider, J. A., Abisambra, J. F., Abner, E. L., Alafuzoff, I., Arnold, S. E., Attems, J., Beach, T. G., Bigio, E. H., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1349-0 · Cited by 1,467 · cited 7×
“The finding that the absence of NPs was associated with a restricted distribution of tau pathology (Braak NFT stage #IV) is consistent with previous reports and further supports the assertions that PART is predominantly a temporal lobe pathology and that isocortical spread of NFTs is highly correlated with the presenc…”
BackgroundResultInfluentialSelf-citationBeach, T. G., Monsell, S. E., Phillips, L. E., & Kukull, W. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31824b211b · Cited by 1,103 · cited 4×
“Unauthorized reproduction of this article is prohibited. respects are indistinguishable from AD NFTs.11 However, individuals with PART usually display milder cognitive symptoms than patients with AD.9 Some evidence suggests that subjective memory complaints are common in PART12 and that PART dementia is more common in…”
BackgroundInfluentialSelf-citationMorris, J. C., Weintraub, S., Chui, H. C., Cummings, J., DeCarli, C., Ferris, S., Foster, N. L., Galasko, D., Graff-Radford, N., Peskind, E. R., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213865.09806.92 · Cited by 950
Self-citationThe National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set
Beekly, D. L., Ramos, E. M., Lee, W. W., Deitrich, W. D., Jacka, M. E., Wu, J., Hubbard, J. L., Koepsell, T. D., Morris, J. C., & Kukull, W. A. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318142774e · Cited by 907
Self-citationStaging of Alzheimer-Related Cortical Destruction
Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836 · cited 1×
“In AD, cross-sectional autopsy studies suggest that NFTs develop in the medial temporal lobe early and then progress to neocortical regions.(4) Occasional NFTs in the medial temporal lobe are ubiquitous in brain aging, and some patients with dementia without amyloid plaques, tau mutations, or other classifiable tauopa…”
BackgroundJack, C. R., Knopman, D. S., Weigand, S. D., Wiste, H. J., Vemuri, P., Lowe, V., Kantarci, K., Gunter, J. L., Senjem, M. L., Ivnik, R. J., et al. (2012) · Annals of Neurology · doi:10.1002/ana.22628 · Cited by 602
Alafuzoff, I., Arzberger, T., Al‐Sarraj, S., Bodi, I., Bogdanovic, N., Braak, H., Bugiani, O., Del‐Tredici, K., Ferrer, I., Gelpi, E., et al. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00147.x · Cited by 467 · cited 1×
“While these findings are consistent with previous autopsy studies demonstrating that severe PART is correlated with cognitive impairment,(24,25) more sensitive or quantitative measures of tangle burden might be necessary to demonstrate robust associations at milder NFT disease stages, which are difficult to accurately…”
ResultCerebral amyloid angiopathy pathology and cognitive domains in older persons
Arvanitakis, Z., Leurgans, S. E., Wang, Z., Wilson, R. S., Bennett, D. A., & Schneider, J. A. (2011) · Annals of Neurology · doi:10.1002/ana.22112 · Cited by 383
Cited by
Defining Cognitive Reserve and Implications for Cognitive Aging
Pettigrew, C., & Soldan, A. (2019) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-019-0917-z · Cited by 419
Besser, L. M., Kukull, W. A., Teylan, M. A., Bigio, E. H., Cairns, N. J., Kofler, J. K., Montine, T. J., Schneider, J. A., & Nelson, P. T. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly049 · Cited by 224
“Since January 2017, published manuscripts using the NP data focused on a wide range of topics including the genetics of HS (28), factors associated with being symptomatic (29) and cognitive decline observed in PART (30), mixed pathologies and cognitive decline (2), pathologic correlates of Lewy body disease (31), the…”
BackgroundSelf-citationBell, W. R., An, Y., Kageyama, Y., English, C., Rudow, G. L., Pletnikova, O., Thambisetty, M., O'Brien, R., Moghekar, A. R., Albert, M. S., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.07.215 · Cited by 111
“2) and that PART can cause cognitive impairment independently of Ab deposition [26].”
BackgroundDifferences in cognitive impairment in primary age-related tauopathy versus Alzheimer disease
Besser, L. M., Mock, C., Teylan, M. A., Hassenstab, J., Kukull, W. A., & Crary, J. F. (2019) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly132 · Cited by 45
Self-citationTeylan, M., Besser, L. M., Crary, J. F., Mock, C., Gauthreaux, K., Thomas, N. M., Chen, Y.-C., & Kukull, W. A. (2019) · Laboratory Investigation · doi:10.1038/s41374-019-0186-0 · Cited by 35
Self-citation
Metadata
- Authors
- Besser, L. M., Crary, J. F., Mock, C., & Kukull, W. A.
- Venue
- Neurology
- Published
- 2017-10-17
- Volume
- 89
- Issue
- 16
- Pages
- 1707-1715
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2756191472
- Cited by
- 59
- References
- 12
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy. https://app.cochat.ai/papers/10.1212/wnl.0000000000004521
- The paper
- Besser, L. M., Crary, J. F., Mock, C., & Kukull, W. A. (2017). Comparison of symptomatic and asymptomatic persons with primary age-related tauopathy. Neurology. https://doi.org/10.1212/wnl.0000000000004521
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.